Calcipotriene Ointment

Calcipotriene Ointment

Calcipotriene Ointment Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

Contact dermatitis, including allergic contact dermatitis, has been observed with the use of calcipotriene.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.


Calcipotriene ointment, 0.005%, is indicated for the treatment of plaque psoriasis in adults. The safety and effectiveness of topical calcipotriene in dermatoses other than psoriasis have not been established.


There is currently no drug history available for this drug.

Other Information

Calcipotriene ointment, 0.005% contains the compound calcipotriene, a synthetic vitamin D3 derivative for topical dermatological use.

Chemically, calcipotriene is (5Z,7E,22E,24S)-24-cyclopropyl-9,10-secochola- 5,7,10(19),22-tetraene-1α,3β,24-triol-, with the empirical formula C27H40O3, a molecular weight of 412.6, and the following structural formula:


Calcipotriene is a white or off-white crystalline substance. Calcipotriene ointment contains calcipotriene 50 μg/g in an ointment base of disodium phosphate dihydrate, edetate disodium, mineral oil, petrolatum, propylene glycol, α-tocopherol, steareth-2 and purified water.

Calcipotriene Ointment Manufacturers

  • Glenmark Generics Inc., Usa
    Calcipotriene Ointment [Glenmark Generics Inc., Usa]
  • Taro Pharmaceuticals U.s.a., Inc.
    Calcipotriene Ointment [Taro Pharmaceuticals U.s.a., Inc.]
  • Prasco Laboratories
    Calcipotriene Ointment [Prasco Laboratories]

Login To Your Free Account